ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q2 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,162,705 | -9.9% | 1,065,372 | +2.1% | 0.00% | – |
Q2 2023 | $2,399,961 | -16.6% | 1,043,461 | +9.9% | 0.00% | -100.0% |
Q1 2023 | $2,878,167 | +34.5% | 949,890 | +3.4% | 0.00% | – |
Q4 2022 | $2,140,667 | +24.5% | 918,741 | +2.0% | 0.00% | – |
Q3 2022 | $1,720,000 | -29.2% | 900,547 | +0.4% | 0.00% | -100.0% |
Q2 2022 | $2,431,000 | +5.4% | 896,972 | +15.9% | 0.00% | – |
Q1 2022 | $2,307,000 | -19.3% | 774,239 | +5.4% | 0.00% | – |
Q4 2021 | $2,857,000 | -4.9% | 734,468 | +4.8% | 0.00% | -100.0% |
Q3 2021 | $3,005,000 | +37.9% | 700,504 | -2.6% | 0.00% | – |
Q2 2021 | $2,179,000 | +393.0% | 719,159 | +441.9% | 0.00% | – |
Q1 2021 | $442,000 | +9.1% | 132,703 | +16.2% | 0.00% | – |
Q4 2020 | $405,000 | +8.0% | 114,203 | -4.6% | 0.00% | – |
Q3 2020 | $375,000 | +99.5% | 119,683 | +16.4% | 0.00% | – |
Q2 2020 | $188,000 | -69.2% | 102,787 | -64.9% | 0.00% | – |
Q2 2019 | $610,000 | -45.7% | 293,078 | -6.6% | 0.00% | – |
Q1 2019 | $1,123,000 | -5.7% | 313,760 | +0.8% | 0.00% | – |
Q4 2018 | $1,191,000 | -62.0% | 311,118 | -6.2% | 0.00% | -100.0% |
Q3 2018 | $3,135,000 | +44.9% | 331,708 | +11.9% | 0.00% | 0.0% |
Q2 2018 | $2,164,000 | – | 296,416 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |